News Bulletin
Friday, May 15, 2026
Evening Edition
Economic Numbers:
|
Time |
Event |
Actual |
Forecast |
Previous |
|
8:30 |
19.6 |
7.3 |
11 |
|
|
9:15 |
0.0135 |
|
0.0076 |
|
|
9:15 |
0.007 |
0.003 |
-0.003 |
|
|
9:15 |
0.006 |
0.002 |
0.001 |
|
|
9:15 |
0.761 |
0.758 |
0.757 |
|
|
13:00 |
415 |
|
410 |
|
|
13:00 |
551 |
|
548 |
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
49,526.17 |
47,990.30 |
47,458.10 |
|
NASDAQ |
26,225.14 |
23,566.77 |
22,957.50 |
|
S&P 500 |
7,408.50 |
6,918.21 |
6,781.15 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
COMPANY |
EPS |
Consensus |
Previous |
Revenue |
Consensus |
Previous |
MarketCap |
Fiscal |
Time |
|
3.33 |
506.27M |
$17.86B |
Q4 |
AM |
|||||
|
1.43 |
398.65M |
$9.44B |
Q1 |
AM |
|||||
|
2.47 |
1.12B |
$8.76B |
Q1 |
AM |
|||||
|
|
|
$8.26B |
Q1 |
PM |
|||||
|
0.39 |
885.76M |
$2.34B |
Q1 |
PM |
|||||
|
|
67.94M |
$1.76B |
Q1 |
PM |
Market
News:
Here are some of the biggest premarket US stock movers today:
Accuray Incorporated (ARAY) and the University of Wisconsin School
of Medicine and Public Health announced a 10-year strategic collaboration to
advance personalized cancer treatments using Accuray’s
Stellar adaptive radiation therapy platform.
Nvidia (NASDAQ:NVDA) received U.S. approval this week to
sell H200 GPUs to roughly 10 Chinese firms, including Alibaba,
Tencent, and ByteDance. The
approval creates potential for 3-5% revenue upside in calendar year 2027, with
a best-case scenario of 10% added to CY27 estimates, Gene Munster of Deepwater
Asset Management said.
Exxon Mobil
(XOM) has criticized Institutional Shareholder Services
for recommending against its proposal to redomicile
to Texas, claiming the proxy advisor relied on flawed analysis and failed to
disclose a conflict of interest related to ongoing litigation with the Texas
Attorney General.
Amgen Inc
(NASDAQ:AMGN) shares fell 2.1% Friday following developments
related to Tavneos, a drug for rare kidney diseases
that the company acquired through its $16.6 billion purchase of Horizon
Therapeutics in 2023.
Geo Group
Inc (NYSE:GEO) shares fell 1% Friday following the release of a
California Department of Justice report detailing deteriorating conditions at
immigrant detention facilities across the state.
For internal use only